Evidence map›Paper›PMID 30202000›Full record

ArticleScientific reports2018

Transferrin as a thermosensitizer in radiofrequency hyperthermia for cancer treatment.

Hea-Jong Chung, Heui-Kwan Lee, Ki Beom Kwon, Hyeon-Jin Kim, Seong-Tshool Hong

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Nanoparticle-Mediated Hyperthermia and Cytotoxicity Mechanisms in Cancer.International journal of molecular sciences · 2023
    Review
  6. Identification of the Intestinal Microbes Associated with Locomotion.International journal of molecular sciences · 2023
    Article
  7. Article
  8. Overview of Cancer Metabolism and Signaling Transduction.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Roborovski hamsterVirulence · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Dark Antibacterial Activity of Rose Bengal.International journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hea-Jong ChungDepartment of Biomedical Sciences and Institute for Medical Science, Chonbuk National University Medical School, Jeonju, Chonbuk, 54907, South Korea.
Heui-Kwan LeeDeparment of Radiation oncology, Presbyterian Medical Center, Seonam University Medical School, Jeonju, Chonbuk, 54987, South Korea.
Ki Beom KwonSchool of Public Health, University of Washington, Seattle, Washington, United States of America.
Hyeon-Jin KimJINIS BDRD institute, JINIS Biopharmaceuticals Co., 913 Gwahak-Ro, Bongdong, Wanju, Chonbuk, 55321, South Korea.
Seong-Tshool HongDepartment of Biomedical Sciences and Institute for Medical Science, Chonbuk National University Medical School, Jeonju, Chonbuk, 54907, South Korea. seonghong@chonbuk.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the main characteristics of cancer tissues is poor development of neovascularization that results in a limited blood circulation. Because of this phenomenon, it is harder for cancer tissues to diffuse their elevated heat into other parts of the body. The scientific principle of radiofrequency hyperthermia relies on this quality of cancer tissues which with higher temperature becomes more apparent. Despite the obvious necessity to selectively heat the cancer tissue for radiofrequency hyperthermia, a proper thermosensitizer has not been developed until now. Here, we show that transferrin containing ferric ion could be an ideal thermosensitizer for the increased efficiency of radiofrequency hyperthermia. In our result, the ferric ion-enriched cancer tissues dramatically react with 13.56 MHz radiofrequency wave to cause cancer-selective dielectric temperature increment. The overall anticancer efficacy of a 13.56 MHz radiofrequency hyperthermia using transferrin as a thermosensitizer was much higher than the oncotherapeutic efficacy of paclitaxel, successfully eradicating cancer in a tumor-xenografted mouse experiment.

Indexed as

AnimalsCell Line, TumorCombined Modality TherapyHumansInjections, IntravenousMaleMiceMice, Inbred BALB CMice, Inbred C57BLMice, NudeNeoplasmsPrimary Cell CultureShort-Wave TherapyTransferrinTreatment OutcomeXenograft Model Antitumor AssaysTransferrin

Identifiers

PMID30202000
PMCPMC6131143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.